A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models-Reference-Cited by-同舟云学术

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

Published:2014-01-17 Issue:4 Volume:135 Page:820-829
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Adlard Amy L.¹,Dovedi Simon J.²,Telfer Brian A.¹,Koga-Yamakawa Erina³,Pollard Charlotte²,Honeychurch Jamie²,Illidge Timothy M.²,Murata Masashi³,Robinson David T.⁴,Jewsbury Philip J.⁴,Wilkinson Robert W.⁴,Stratford Ian J.¹

Affiliation:

1. Experimental Oncology Group; School of Pharmacy and Pharmaceutical Sciences; Manchester Cancer Research Centre; University of Manchester; Manchester Academic Health Sciences Centre; United Kingdom

2. Targeted Therapy Group; Institute of Cancer Sciences, Manchester Cancer Research Centre; University of Manchester; Manchester Academic Health Sciences Centre; United Kingdom

3. Dainippon Sumitomo Pharma; Konohana-ku Osaka Japan

4. AstraZeneca Pharmaceuticals Ltd.; Alderley Park Cheshire United Kingdom

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Innovations in image-guided radiotherapy;Verellen;Nat Rev Cancer,2007

2. Innovations in radiation therapy (RT) for breast cancer;Lee;Breast,2009

3. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001

4. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines;Delaney;Cancer,2005

5. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy;Reits;J Exp Med,2006

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation;BMC Immunology;2024-07-25

2. Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD‐1 antibody for BRAF‐mutated melanoma;Cancer Science;2024-06-18

3. Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas;Seminars in Radiation Oncology;2024-04

4. Cholesterolized TLR7 agonist liposomes combined with radiotherapy elicit antitumor immunity through oxidized mitochondrial DNA- driven inflammasome pathway;2023-12-08

5. Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations;JNCI: Journal of the National Cancer Institute;2023-06-22